Financials Establishment Labs Holdings Inc.

Equities

ESTA

VGG312491084

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 20:50:28 10/05/2024 BST 5-day change 1st Jan Change
56.66 USD -0.31% Intraday chart for Establishment Labs Holdings Inc. +7.36% +119.08%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 569.8 882.2 1,622 1,598 668.2 1,561 - -
Enterprise Value (EV) 1 569.8 847.5 1,621 1,598 668.2 1,761 1,769 1,748
P/E ratio -14.9 x -23.1 x -39.3 x -21.3 x -8.43 x -32.5 x -77.9 x 188 x
Yield - - - - - - - -
Capitalization / Revenue 6.36 x 10.4 x 12.8 x 9.88 x 4.05 x 8.62 x 6.4 x 5.03 x
EV / Revenue 6.36 x 10 x 12.8 x 9.88 x 4.05 x 9.73 x 7.25 x 5.64 x
EV / EBITDA - -34.5 x -75.7 x -44.7 x -11 x -178 x 98 x 39.8 x
EV / FCF - - - -29 x - -53.4 x 104 x 43.7 x
FCF Yield - - - -3.44% - -1.87% 0.96% 2.29%
Price to Book - 11.7 x 32 x - - - - -
Nbr of stocks (in thousands) 20,601 23,438 24,004 24,342 25,808 27,460 - -
Reference price 2 27.66 37.64 67.59 65.65 25.89 56.83 56.83 56.83
Announcement Date 16/03/20 10/03/21 01/03/22 27/02/23 28/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 89.56 84.68 126.7 161.7 165.2 180.9 243.8 310.2
EBITDA 1 - -24.57 -21.42 -35.79 -60.86 -9.912 18.05 43.88
EBIT 1 -30.94 -27.92 -25.14 -39.66 -65.03 -26.51 -6.21 31.36
Operating Margin -34.55% -32.97% -19.84% -24.53% -39.37% -14.65% -2.55% 10.11%
Earnings before Tax (EBT) 1 -37.51 -38.02 -39.71 -72.82 -78.58 -47.87 -21.14 20.05
Net income 1 -38.15 -38.12 -41.14 -75.21 -78.5 -49.26 -21.63 18.78
Net margin -42.59% -45.02% -32.47% -46.51% -47.53% -27.22% -8.87% 6.05%
EPS 2 -1.860 -1.630 -1.720 -3.080 -3.070 -1.748 -0.7292 0.3028
Free Cash Flow 1 - - - -55.02 - -33 17 40
FCF margin - - - -34.02% - -18.24% 6.97% 12.89%
FCF Conversion (EBITDA) - - - - - - 94.17% 91.16%
FCF Conversion (Net income) - - - - - - - 213%
Dividend per Share 2 - - - - - - - -
Announcement Date 16/03/20 10/03/21 01/03/22 27/02/23 28/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 29.04 35.31 38.45 41.19 38.24 43.81 46.52 48.56 38.51 31.56 37.1 43.23 46.76 53.81 52.99
EBITDA 1 -8.096 -8.44 -4.622 -9.45 -9.539 -12.17 -7.224 -12.58 -19.98 -20.89 -8 -5.2 -3 1.126 -0.9633
EBIT 1 -9.044 -9.366 -5.575 -10.41 -10.52 -13.16 -8.16 -13.71 -21.04 -22.12 -9 -8.525 -5.728 -3.3 -4.567
Operating Margin -31.14% -26.52% -14.5% -25.26% -27.5% -30.04% -17.54% -28.24% -54.64% -70.07% -24.26% -19.72% -12.25% -6.13% -8.62%
Earnings before Tax (EBT) 1 -14.61 -13.4 -5.534 -36.54 -18 -12.74 -11.11 -15.82 -28.6 -23.05 -14.3 -13.66 -11.24 -7.039 -7.867
Net income 1 -14.68 -14.19 -5.933 -37.11 -18.61 -13.56 -11.94 -16.74 -29.27 -20.54 -14.85 -14.12 -11.6 -7.399 -8.467
Net margin -50.55% -40.19% -15.43% -90.08% -48.65% -30.95% -25.67% -34.48% -76.02% -65.09% -40.03% -32.67% -24.81% -13.75% -15.98%
EPS 2 -0.6100 -0.5900 -0.2400 -1.520 -0.7600 -0.5500 -0.4800 -0.6500 -1.120 -0.7900 -0.5833 -0.4987 -0.4029 -0.2650 -0.2688
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 09/11/21 01/03/22 09/05/22 08/08/22 07/11/22 27/02/23 08/05/23 08/08/23 07/11/23 28/02/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - 200 208 188
Net Cash position 1 - 34.7 1.51 - - - - -
Leverage (Debt/EBITDA) - - - - - -20.2 x 11.53 x 4.276 x
Free Cash Flow 1 - - - -55 - -33 17 40
ROE (net income / shareholders' equity) - -50.9% -65.5% - - -154% -68.2% -22.7%
ROA (Net income/ Total Assets) - - - - - -18.1% -8.25% 1.53%
Assets 1 - - - - - 272.3 262.3 1,229
Book Value Per Share - 3.210 2.110 - - - - -
Cash Flow per Share - - - -2.130 - - - -
Capex 1 - 2.42 2.43 2.85 - 20 17 19
Capex / Sales - 2.86% 1.91% 1.76% - 11.05% 6.97% 6.12%
Announcement Date 16/03/20 10/03/21 01/03/22 27/02/23 28/02/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
56.83 USD
Average target price
60.43 USD
Spread / Average Target
+6.33%
Consensus
  1. Stock Market
  2. Equities
  3. ESTA Stock
  4. Financials Establishment Labs Holdings Inc.